In conclusion, the exclusive PTM of NuMA in cancer cells by polyADP-ribosylation and by Pim1 phosphorylation unveils a new target for the eradication of cancer cells, exploiting the dependence of the bipolar clustering of NuMA in mitotic spindles on its PTM. The gene discussed is NUMA1; the disease is cancer.